Patent №
US 12,530,770
Granted
2026-01-20
Filed 2023
Owner
University Hospitals Cleveland Medical Center
Lab
—
AI components
0
Assignment
None on record
Dataset
AIPD
Application
18461686
The present disclosure relates to a method. The method includes accessing automatically segmented liver data and automatically segmented spleen data from a patient. The automatically segmented liver data is used to determine a liver attenuation and the automatically segmented spleen data is used to determine a spleen attenuation. A liver-to-spleen attenuation ratio is determined from the liver attenuation and the spleen attenuation. A hepatic steatosis determination is made from the liver-to-spleen attenuation ratio.
G16H 50/30G06T 7/0012G06T 7/11G16H 50/20A61B 5/0033A61B 5/0073A61B 5/416A61B 5/4244+4 more
Ownership
University Hospitals Cleveland Medical Center
From the same owner
PREDICTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) FROM AI ANALYSIS OF PERICORONARY FAT IN CT IMAGESUS 12,573,036 · 2026ARTIFICIAL-INTELLIGENCE-BASED FACILITATION OF HEALTHCARE DELIVERYUS 12,278,005 · 2025COMBINATION OF FEATURES FROM BIOPSIES AND SCANS TO PREDICT PROGNOSIS IN SCLCUS 12,159,403 · 2024BLOOD TRANSFUSION MANAGEMENT USING ARTIFICIAL INTELLIGENCE ANALYTICSUS 11,935,653 · 2024BLOOD TRANSFUSION MANAGEMENT USING ARTIFICIAL INTELLIGENCE ANALYTICSUS 11,929,175 · 2024DIELECTRIC SENSING TO CHARACTERIZE HEMOSTATIC DYSFUNCTIONUS 11,774,388 · 2023MULTICONTRAST SYNTHETIC LATE GADOLINIUM ENHANCEMENT IMAGING USING POST-CONTRAST MAGNETIC RESONANCE FINGERPRINTINGUS 11,719,778 · 2023ARTIFICIAL-INTELLIGENCE-BASED FACILITATION OF HEALTHCARE DELIVERYUS 11,437,125 · 2022